Januvia, Byetta Pancreatic Cancer Risks Revealed in Adverse Event Report Analysis
A recent analysis that looks at side effects associated with diabetes drugs on today’s market may lend further evidence to Byetta lawsuit allegations that the medication may cause pancreatitis and pancreatic cancer, according to a findings published in April.
The research was led by Adverse Events (AE), a California-based company that studies post-market side effect information, and incorporated data from the U.S. Food and Drug Administration (FDA)’s Adverse Event Reporting Systems. AE looked at 11 medications used to treat Type 2 diabetes, according to an April report, and looked at complaints that noted instances of hospitalization, disabilities, and death.
AE Report Logs Complaints Similar to those Alleged in Byetta Lawsuit Allegations
Included in the analysis were medications part of a class referred to as GLP-1 Agonists, which includes Byetta and Victoza; two drugs currently named in dozens of federal lawsuits pending in a multidistrict litigation underway in the U.S. District Court, Southern District of California. When comparing these products against Bydureon, researchers found this medication to have lower side effect risks than the other two.
“Our review of post-approval AE data suggest disproportionally elevated reporting of gastrointestinal issues, pancreatitis, and both pancreatic and thyroid cancers linked to the GLP-1 agonists,” AE concluded.
The study also looked at side effects associated with DPP-4 inhibitors, which counts Janumet and Januvia as part of its category.
Research found that, “Within the class, Janumet and Januvia (both containing sitagliptin) had the highest associations with these side effects. “
This information may be particular noteworthy to claimants involved in Januvia pancreatic cancer and pancreatitis lawsuits, who similarly allege that the drug’s manufacturer failed to warn about these risks in its marketing of the medication. Many lawsuits over this Type 2 diabetes medication have also been filed in the Southern District of California, where court records estimate that 350 lawsuits also filed over Byetta, Victoza and similar products in April 2014.
What’s more, the number of U.S. residents with Type 2 diabetes is on the rise. A statistic from The Centers for Disease Control indicates that 26 million people in the U.S. are living with the disease, which represents a 10 percent increase in three years.
Pursuing a Byetta Lawsuit
Speak with one of our Firm’s attorneys today to learn more about Byetta lawsuits, and to find out whether you may be eligible to file a claim alleging pancreatic cancer, pancreatitis or thyroid cancer. Call us now at (877) 779-1414.